TechBio

COPENHAGEN, Denmark — September 14, 2026 Evaxion A/S announced that it has begun applying its proprietary AI-Immunology™ platform to...

DALLAS, Aug. 14, 2026 Lantern Pharma Inc. is strengthening its position at the intersection of artificial intelligence and precision...

COPENHAGEN, Denmark, August 14, 2026 Evaxion A/S (NASDAQ: EVAX) is preparing to provide a business update and second-quarter 2026...

LAGUNA HILLS, California & SHANGHAI, China, July 6, 2026 Aureka, an AI TechBio company developing next-generation infrastructure for AI-driven...

COPENHAGEN, Denmark, July 1, 2026 Evaxion A/S announced that it will present new preclinical data for its investigational cytomegalovirus...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands, and SHANGHAI, China, June 15, 2026 Harbour BioMed and BioMap have announced a long-term strategic...